<DOC>
	<DOCNO>NCT00695032</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood urine patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study evaluate kidney damage patient receive cisplatin ifosfamide solid tumor .</brief_summary>
	<brief_title>Kidney Damage Patients Receiving Cisplatin Ifosfamide Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Identify evaluate early biomarkers renal toxicity patient solid tumor treat cisplatin ifosfamide . Secondary - Correlate modification biomarker study blood concentration cisplatin . OUTLINE : Patients receive standard chemotherapy comprise cisplatin and/or ifosfamide . Blood urine sample collect day 1 2 ( day 3 receive ifosfamide ) first 3 course . Samples analyze determine plasma concentration residual cisplatin obtain urinary-protein profile measure renal toxicity .</detailed_description>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis solid tumor Any location allow Metastatic disease allow Planned treatment comprise cisplatin and/or ifosfamide standard chemotherapy PATIENT CHARACTERISTICS : Inclusion criterion : Life expectancy &gt; 3 month Creatinine clearance â‰¥ 60 mL/min Must available follow Not pregnant nursing Not guardianship prison Exclusion criterion : Prior drugrelated nephrotoxicity Acute , uncontrolled urinary infection &gt; 48hours Preexisting hemorrhagic cystitis Weak bladder Bilateral obstruction urinary tract Insufficient , severe bone marrow hypoplasia Cardiorespiratory condition contraindicate hyperhydration Hearing impairment Hypersensitivity cisplatin product contain platinum Major psychiatric condition ( severe depression , psychosis , dementia ) PRIOR CONCURRENT THERAPY : No prior yellow fever vaccine , live attenuate vaccine , phenytoin No concurrent participation another biomedical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>renal toxicity</keyword>
	<keyword>chemotherapeutic agent toxicity</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>